Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Current Opinion in Pharmacology
|
February 21, 2006
Role of HMGB1 in cardiovascular diseases
Wei Li, Andrew E Sama, Haichao Wang
Shock (Augusta, Ga.)
|
April 1, 2009
Novel HMGB1-inhibiting therapeutic agents for experimental sepsis
Haichao Wang, Mary F Ward, Andrew E Sama
Expert Opinion on Therapeutic Targets
|
January 8, 2014
Targeting HMGB1 in the treatment of sepsis
Haichao Wang, Mary F Ward, Andrew E Sama
Molecular Medicine (Cambridge, Mass.)
|
July 10, 2013
Carbenoxolone blocks endotoxin-induced protein kinase R (PKR) activation and high mobility group box 1 (HMGB1) release
Wei Li, Jianhua Li, Andrew E Sama, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
June 24, 2004
Extracellular HMGB1 as a proinflammatory cytokine
Guoqian Chen, Mary F Ward, Andrew E Sama, et al.
International Journal of Clinical and Experimental Medicine
|
December 17, 2008
Caging a Beast in the Inflammation Arena: Use of Chinese Medicinal Herbs to Inhibit a Late Mediator of Lethal Sepsis, HMGB1
Shu Zhu, Wei Li, Jianhua Li, et al.
Expert Reviews in Molecular Medicine
|
November 5, 2008
Therapeutic potential of HMGB1-targeting agents in sepsis
Haichao Wang, Shu Zhu, Rongrong Zhou, et al.
Critical Care Medicine
|
July 31, 2008
Hyperglycemia aggravates endotoxin-induced high mobility group box 1 protein release: yet another reason not to be too sweet
Haichao Wang, Shu Zhu, Mary F Ward, et al.
Novartis Foundation Symposium
|
March 27, 2007
HMGB1 as a potential therapeutic target
Haichao Wang, Wei Li, Richard Goldstein, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
August 4, 2004
Bench to bedside: HMGB1-a novel proinflammatory cytokine and potential therapeutic target for septic patients in the emergency department
Andrew E Sama, Jason D'Amore, Mary F Ward, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Current Opinion in Pharmacology
|
February 21, 2006
Role of HMGB1 in cardiovascular diseases
Wei Li, Andrew E Sama, Haichao Wang
Shock (Augusta, Ga.)
|
April 1, 2009
Novel HMGB1-inhibiting therapeutic agents for experimental sepsis
Haichao Wang, Mary F Ward, Andrew E Sama
Expert Opinion on Therapeutic Targets
|
January 8, 2014
Targeting HMGB1 in the treatment of sepsis
Haichao Wang, Mary F Ward, Andrew E Sama
Molecular Medicine (Cambridge, Mass.)
|
July 10, 2013
Carbenoxolone blocks endotoxin-induced protein kinase R (PKR) activation and high mobility group box 1 (HMGB1) release
Wei Li, Jianhua Li, Andrew E Sama, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
June 24, 2004
Extracellular HMGB1 as a proinflammatory cytokine
Guoqian Chen, Mary F Ward, Andrew E Sama, et al.
International Journal of Clinical and Experimental Medicine
|
December 17, 2008
Caging a Beast in the Inflammation Arena: Use of Chinese Medicinal Herbs to Inhibit a Late Mediator of Lethal Sepsis, HMGB1
Shu Zhu, Wei Li, Jianhua Li, et al.
Expert Reviews in Molecular Medicine
|
November 5, 2008
Therapeutic potential of HMGB1-targeting agents in sepsis
Haichao Wang, Shu Zhu, Rongrong Zhou, et al.
Critical Care Medicine
|
July 31, 2008
Hyperglycemia aggravates endotoxin-induced high mobility group box 1 protein release: yet another reason not to be too sweet
Haichao Wang, Shu Zhu, Mary F Ward, et al.
Novartis Foundation Symposium
|
March 27, 2007
HMGB1 as a potential therapeutic target
Haichao Wang, Wei Li, Richard Goldstein, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
August 4, 2004
Bench to bedside: HMGB1-a novel proinflammatory cytokine and potential therapeutic target for septic patients in the emergency department
Andrew E Sama, Jason D'Amore, Mary F Ward, et al.
Page
of 4